Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
38.41
-0.34 (-0.88%)
Aug 7, 2026, 4:00 PM EDT - Market closed
HRMY Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,237 | 2,160 | 1,966 | 1,834 | 3,285 | 2,508 | |
Market Cap Growth | 12.14% | 9.85% | 7.24% | -44.18% | 30.96% | 21.96% |
Enterprise Value | 1,729 | 1,548 | 1,678 | 1,674 | 3,153 | 2,466 |
Last Close Price | 38.41 | 37.42 | 34.41 | 32.30 | 55.10 | 42.64 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.43 | 13.81 | 13.71 | 15.16 | 18.55 | 73.52 |
Forward PE | 9.75 | 10.05 | 11.82 | 11.14 | 23.01 | 25.27 |
PEG Ratio | 0.34 | 0.39 | 0.47 | 0.73 | - | - |
PS Ratio | 2.33 | 2.49 | 2.75 | 3.15 | 7.50 | 8.21 |
PB Ratio | 2.23 | 2.48 | 2.98 | 3.93 | 8.15 | 13.45 |
P/TBV Ratio | 2.45 | 2.81 | 3.65 | 5.91 | 13.92 | 59.28 |
P/FCF Ratio | 6.30 | 6.21 | 8.99 | 8.37 | 22.76 | 25.53 |
P/OCF Ratio | 6.30 | 6.20 | 8.95 | 8.36 | 22.74 | 25.45 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.80 | 1.78 | 2.35 | 2.88 | 7.20 | 8.07 |
EV/EBITDA Ratio | 6.76 | 6.62 | 7.81 | 7.73 | 21.96 | 23.18 |
EV/EBIT Ratio | 7.50 | 7.43 | 8.80 | 8.72 | 26.24 | 28.17 |
EV/FCF Ratio | 4.87 | 4.45 | 7.68 | 7.64 | 21.85 | 25.10 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.13 | 0.17 | 0.25 | 0.38 | 0.47 | 1.02 |
Debt / EBITDA Ratio | 0.60 | 0.70 | 0.83 | 0.90 | 1.34 | 1.81 |
Debt / FCF Ratio | 0.43 | 0.47 | 0.82 | 0.88 | 1.33 | 1.95 |
Net Debt / Equity Ratio | -0.51 | -0.70 | -0.44 | -0.34 | -0.33 | -0.23 |
Net Debt / EBITDA Ratio | -2.01 | -2.62 | -1.34 | -0.74 | -0.92 | -0.40 |
Net Debt / FCF Ratio | -1.45 | -1.76 | -1.32 | -0.73 | -0.91 | -0.43 |
Asset Turnover | 0.73 | 0.76 | 0.79 | 0.78 | 0.79 | 0.71 |
Inventory Turnover | 40.27 | 31.60 | 24.97 | 25.10 | 19.13 | 13.45 |
Quick Ratio | 3.33 | 3.46 | 3.14 | 2.61 | 4.79 | 5.01 |
Current Ratio | 3.48 | 3.60 | 3.31 | 2.75 | 5.07 | 5.29 |
Return on Equity (ROE) | 19.39% | 20.75% | 25.84% | 29.63% | 61.58% | 24.39% |
Return on Assets (ROA) | 13.11% | 13.55% | 15.99% | 19.21% | 37.63% | 18.80% |
Return on Invested Capital (ROIC) | 37.94% | 48.85% | 42.68% | 49.34% | 100.27% | 78.18% |
Return on Capital Employed (ROCE) | 21.37% | 22.62% | 25.93% | 30.91% | 24.66% | 26.04% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 8.10% | 7.24% | 7.29% | 6.59% | 5.39% | 1.36% |
FCF Yield | 15.87% | 16.11% | 11.12% | 11.95% | 4.39% | 3.92% |
Buyback Yield / Dilution | -0.65% | -1.17% | 4.15% | 1.19% | -3.20% | -119.09% |
Total Shareholder Return | -0.65% | -1.17% | 4.15% | 1.19% | -3.20% | -119.09% |